PT - JOURNAL ARTICLE AU - Disbeschl, Stefanie AU - Surgey, Alun AU - Roberts, Jessica L AU - Hendry, Annie AU - Lewis, Ruth AU - Goulden, Nia AU - Hoare, Zoe AU - Williams, Nefyn AU - Anthony, Bethany Fern AU - Edwards, Rhiannon Tudor AU - Law, Rebecca-Jane AU - Hiscock, Julia AU - Carson-Stevens, Andrew AU - Neal, Richard D AU - Wilkinson, Clare TI - Protocol for a Feasibility study incorporating a Randomised Pilot Trial with an Embedded Process Evaluation and Feasibility Economic Analysis of ThinkCancer!: A primary care intervention to expedite cancer diagnosis in Wales AID - 10.1101/2020.12.01.20241554 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.01.20241554 4099 - http://medrxiv.org/content/early/2020/12/03/2020.12.01.20241554.short 4100 - http://medrxiv.org/content/early/2020/12/03/2020.12.01.20241554.full AB - Background Relative to the rest of Europe, the UK has relatively poor cancer outcomes, with late diagnosis and a slow referral process being major contributors. General practitioners (GPs) are often faced with patients presenting with a multitude of non-specific symptoms that could be cancer. Safety netting can be used to manage diagnostic uncertainty by ensuring patients with vague symptoms are appropriately monitored, which is now even more crucial due to the ongoing Covid-19 pandemic and its major impact on cancer referrals. The ThinkCancer! Workshop is an educational behaviour change intervention aimed at the whole general practice team, designed to improve primary care approaches to ensure timely diagnosis of cancer. The workshop will consist of teaching and awareness sessions, the appointment of a Safety Netting Champion and the development of a bespoke Safety Netting Plan, and has been adapted so it can be delivered remotely. This study aims to assess the feasibility of the ThinkCancer! Intervention for a future definitive randomised controlled trial.Methods The ThinkCancer! study is a randomised, multisite feasibility trial, with an embedded process evaluation and feasibility economic analysis. Twenty-three to 30 general practices will be recruited across Wales, randomised in a ratio of 2:1 of intervention versus control who will follow usual care. The workshop will be delivered by a GP educator and will be adapted iteratively throughout the trial period. Baseline practice characteristics will be collected via questionnaire. We will also collect Primary Care Intervals (PCI), Two Week Wait (2WW) referral rates, conversion rates and detection rates at baseline and six months post-randomisation. Participant feedback, researcher reflections and economic costings will be collected following each workshop. A process evaluation will assess implementation using an adapted Normalisation Measure Development (NoMAD) questionnaire and qualitative interviews. An economic feasibility analysis will inform a future economic evaluation.Discussion This study will allow us to test and further develop a novel evidenced-based complex intervention aimed at general practice teams to expedite the diagnosis of cancer in primary care. The results from this study will inform the future design of a full-scale definitive phase III trial.Trial registratio intended registry: clinicaltrials.govCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialIn process - application was delayed due to Covid-19 and we are currently awaiting approval.Funding StatementThis article presents independent research funded by Cancer Research Wales (CRW). The views expressed are those of the authors and not necessarily those of CRW. This funding source had no role in the design of this trial and will not have any role during its execution, analyses, data interpretation or decision to submit results. This research is also linked to the CanTest Collaborative, which is funded by Cancer Research UK (C8640/A23385), of which RDN is an Associate Director.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has been approved by the Health Research Authority/Health and Care Research Wales (IRAS 256824) and Bangor University (School of Healthcare Sciences, 2019-16498). We did not seek REC Approval; this was not required as the study does not involve patients. Participants are consented at two different time points in the study. Practice managers will consent to participate in the study on behalf of the general medical practice. If the practice has been randomised to the intervention, individual staff participants will be asked for their informed consent at the start of the workshop. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOn completion of the trial, the final datasets generated and/or analysed will be available from the corresponding author on reasonable request. Access to the final datasets will be in accordance with governance policies, Good Clinical Practice (GCP) guidelines and funder arrangements.2WWTwo Week WaitAEAdverse EventCSNCCancer Safety Netting ChampionCSNPCancer Safety Netting PlanDMECData Monitoring and Ethics CommitteeGCPGood Clinical PracticeGDPRGeneral Data Protection RegulationsGPGeneral PractitionerHCSWHealth Care Support WorkerHEAPHealth Economics Analysis PlanHRAHealth Research AuthorityMRCMedical Research CouncilNIHRNational Institute for Health ResearchNWORTHNorth Wales Organisation for Randomisation Trials in HealthPCIPrimary Care IntervalPCPPrimary Care ProviderPISParticipant Information SheetPPIPatient and Public InvolvementR&DResearch and DevelopmentRCTRandomised Controlled TrialRISPResearch Information Sheet for PracticesRECResearch Ethics CommitteeSAESerious Adverse EventSOPStandard Operating ProceduresTSCTrial Steering CommitteeWICKEDWales Interventions and Cancer Knowledge about Early DiagnosisWPWork Package